Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 226 results for "mgm institute of health sciences"

Huge Growth Delivered in Very Small Packages: SeeThruEquity's ...

(Investorideas.com Newswire) Institutional investors are, by and large, unable to own shares in companies with market valuations of less than $100 million, which means most sellside analysts don't write research on very small companies. The paradox: ... Digital Media Net, 3 weeks ago

40 images for mgm institute of health sciences

sciencemag.org, 22 hours ago
Pagosa Springs Sun, 6 days ago
BusinessWeek, 1 week ago
Irish Independent, 2 weeks ago
Irish Independent, 2 weeks ago
680 News, 1 week ago
Diverse, 1 week ago
Capital Bay, 2 weeks ago
Tutorial Finder, 3 weeks ago
Yahoo! News, 3 weeks ago
Duke University

Emily Derbyshire: Prospecting for Malaria Drugs

Durham, NC - Chemist Emily Derbyshire combines expertise in chemistry with an interest in human health. Photo by Duke University Photography Emily Derbyshire reaches into a nondescript beige incubator that looks like a dorm room mini-fridge and ...
 Duke University1 month ago
Pacific Standard

Gambling With America's Health

Publicly, Scott Stevens, a chief operating officer of a company in Steubenville, Ohio, was a well-regarded member of his community. A married father of three, he was active in his local Catholic church, involved with high school sports teams, and ...
 Pacific Standard2 months ago

American International College Offers MBA in Resort and Casino Management

PRWeb The new MBA in Resort and Casino Management offered at American International College (AIC) is representative of the College's responsiveness to regional economic opportunities. With the Casino bill remaining intact in the Commonwealth, AIC ...
 Wall Street Business Network2 days ago
[x]  

Identified Hospital by States and UTS for Treatment of Ebola Virus Disease

List of hospitals earmarked by the State/Union Territories for treatment of Ebola Virus Disease Delhi November 25, 2014 Last Updated at 14:20 IST List of hospitals earmarked by the State/Union Territories for treatment of Ebola Virus Disease is ...
 Business Standard India2 days ago

Threshold announces encouraging interim data from Phase I/II glioblastoma trial

Threshold Pharmaceuticals, Inc., a biotechnology company, has announced encouraging interim data from a US investigator-sponsored Phase I/II clinical trial of its anticancer drug, TH-302, in combination with bevacizumab for the treatment of ...
 Individual.com2 days ago THLD: Threshold's Provides an Update on its Phase I/II Trial using TH-302 in Glioblastoma  Yahoo! Finance1 week ago Threshold Pharmaceuticals Announces Phase 1/2 Interim Data Signaling Activity of TH-302 Plus Bevacizumab (Avastin(R)) in Patients With Glioblastoma  Pettinga Financial Advisors1 week ago Threshold Pharmaceuticals, Inc. Announces Phase 1/2 Interim Data Signaling Activity Of TH-302 Plus Bevacizumab (Avastin(R)) In Patients With Glioblastoma  BioSpace1 week ago
[x]  

Q&A: The IMPAACT P1115 HIV Clinical Trial

See related news release . What is the IMPAACT P1115 clinical trial? The IMPAACT P1115 clinical trial is a Phase I/II proof-of-concept study exploring whether giving anti-HIV therapy soon after birth to infants who became infected with HIV in ...
 NIAID1 week ago

Bristol-Myers Squibb Company Release: Study Comparing Opdivo (Nivolumab) To Chemotherapy In Treatment Na??ve Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor To Demonstrate A Survival Benefit In A Phase 3 Trial

Opdivo demonstrated superior overall survival vs. dacarbazine with a one-year survival rate of 73% vs. 42% and a 58% decrease in the risk of death (Hazard Ratio [HR] = 0.42, P Objective response rate was significantly higher for Opdivo than ...
 BioSpace1 week ago CheckMate-066 study comparing Opdivo to chemotherapy to treat patients with nave advanced melanoma meets primary endpoint  PharmaBiz1 week ago Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Nave Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial  CNBC1 week ago ONO PHARMACEUTICAL : Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Naive Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial(85.8KB)  4 Traders1 week ago
[x]  

Janssen to Demonstrate Breadth of Oncology Portfolio with 42 Clinical Data Presentations at the 2014 American Society of Hematology (ASH) Annual Meeting

- Note: This release corresponds to ASH abstracts 22, 31, 78, 84, 176, 327, 505, 2096, 2312, 3448, 3474, 4454, 4469, 4680 PR Newswire RARITAN, N.J., Nov. 6, 2014 RARITAN, N.J. , Nov. 6, 2014 /PRNewswire/ -- Janssen Research & ...
 Reuters3 weeks ago JOHNSON & JOHNSON : Janssen to Demonstrate Breadth of Oncology Portfolio with 41 Clinical Data Presentations at the 2014 American Society of Hematology (ASH) Annual Meeting  4 Traders2 weeks ago Janssen Research & Development To Demonstrate Breadth Of Oncology Portfolio With 42 Clinical Data Presentations At The 2014 American Society of Hematology Annual Meeting  BioSpace3 weeks ago
[x]  
Securities Technology Monitor

Cornerstone Pharmaceuticals Announces Positive Phase I Data for CPI-613 in Relapsed or Refractory AML Patients to be Presented at 2014 ASH Annual Meeting

Company News: Page (1) of 1 - 11/06/14 print page (November 06, 2014) CRANBURY, N.J., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer ...
 Review Seeker3 weeks ago Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer  Tutorial Finder3 weeks ago Cornerstone Pharmaceuticals' CPI-613 Phase I Hematologic Malignancies Trial Data Published in AACR's Clinical Cancer Research  RCL Advisors1 month ago Cornerstone Pharmaceuticals, Inc.' CPI-613 Phase I Hematologic Malignancies Trial Data Published In /i>  BioSpace1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less